| E6 and E7 gene silencing and transformed phenotype of human papillomavirus 16–positive oropharyngeal cancer cells T Rampias, C Sasaki, P Weinberger, A Psyrri Journal of the National Cancer Institute 101 (6), 412-423, 2009 | 326 | 2009 |
| Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma M Vassilakopoulou, M Avgeris, V Velcheti, V Kotoula, T Rampias, ... Clinical Cancer Research 22 (3), 704-713, 2016 | 213 | 2016 |
| A new tumor suppressor role for the Notch pathway in bladder cancer T Rampias, P Vgenopoulou, M Avgeris, A Polyzos, K Stravodimos, ... Nature medicine 20 (10), 1199-1205, 2014 | 200 | 2014 |
| Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells T Rampias, E Boutati, E Pectasides, C Sasaki, P Kountourakis, ... Molecular Cancer Research 8 (3), 433-443, 2010 | 181 | 2010 |
| The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact G Mountzios, T Rampias, A Psyrri Annals of oncology 25 (10), 1889-1900, 2014 | 168 | 2014 |
| The lysine‐specific methyltransferase KMT 2C/MLL 3 regulates DNA repair components in cancer T Rampias, D Karagiannis, M Avgeris, A Polyzos, A Kokkalis, Z Kanaki, ... EMBO reports 20 (3), e46821, 2019 | 132 | 2019 |
| Molecular mechanisms of HPV induced carcinogenesis in head and neck T Rampias, C Sasaki, A Psyrri Oral oncology 50 (5), 356-363, 2014 | 123 | 2014 |
| The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck A Psyrri, T Rampias, JB Vermorken Annals of oncology 25 (11), 2101-2115, 2014 | 115 | 2014 |
| RAS/PI3K crosstalk and cetuximab resistance in head and neck squamous cell carcinoma T Rampias, A Giagini, S Siolos, H Matsuzaki, C Sasaki, A Scorilas, ... Clinical Cancer Research 20 (11), 2933-2946, 2014 | 106 | 2014 |
| Targeting DNA repair in cancer: current state and novel approaches A Klinakis, D Karagiannis, T Rampias Cellular and Molecular Life Sciences 77, 677-703, 2020 | 85 | 2020 |
| Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis E Pectasides, AM Egloff, C Sasaki, P Kountourakis, B Burtness, ... Clinical Cancer Research 16 (8), 2427-2434, 2010 | 72 | 2010 |
| A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening P Kaldrymides, N Mytakidis, T Anagnostopoulos, M Vassiliou, A Tertipi, ... Clinical endocrinology 64 (5), 561-566, 2006 | 57 | 2006 |
| Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma E Pectasides, T Rampias, P Kountourakis, C Sasaki, D Kowalski, ... Clinical Cancer Research 17 (9), 2947-2954, 2011 | 53 | 2011 |
| N-terminal domain mutations of the spike protein are structurally implicated in epitope recognition in emerging SARS-CoV-2 strains A Klinakis, Z Cournia, T Rampias Computational and Structural Biotechnology Journal 19, 5556-5567, 2021 | 52 | 2021 |
| Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients I Konstantopoulou, T Rampias, A Ladopoulou, G Koutsodontis, S Armaou, ... Breast cancer research and treatment 107, 431-441, 2008 | 52 | 2008 |
| Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC) E Pectasides, T Rampias, C Sasaki, C Perisanidis, V Kouloulias, ... PloS one 9 (4), e94273, 2014 | 51 | 2014 |
| Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck A Psyrri, C Sasaki, M Vassilakopoulou, G Dimitriadis, T Rampias Head and neck pathology 6, 121-128, 2012 | 51 | 2012 |
| Resolving DNA damage: epigenetic regulation of DNA repair P Karakaidos, D Karagiannis, T Rampias Molecules 25 (11), 2496, 2020 | 48 | 2020 |
| TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection A Klinakis, T Rampias EBioMedicine 58, 2020 | 45 | 2020 |
| HDAC inhibitors: dissecting mechanisms of action to counter tumor heterogeneity D Karagiannis, T Rampias Cancers 13 (14), 3575, 2021 | 43 | 2021 |
Amanda PsyrriNational Kapodistrian University of Athens在 med.uoa.gr 的电子邮件经过验证
